Ho AL. Immunotherapy, Chemotherapy, or Both: Options for First-Line Therapy for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. J Clin Oncol 2022 Oct 12:JCO2201408. doi: 10.1200/JCO.22.01408.
PMID: 36223554